Table 3 Estimates of 6-month survival without distant brain failure based on a new nomogram[80]
From: Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
Primary tumor type | 1-3 BM, stable systemic disease | 1-3 BM, progressive systemic disease | 4-13 BM, stable systemic disease | 4-13 BM, progressive systemic disease |
|---|---|---|---|---|
Renal cell cancer | 69% | 67% | 48% | 46% |
Malignant melanoma | 57% | 55% | 32% | 30% |
Lung, adeno ca | 74% | 72% | 55% | 53% |
Lung, squamous ca | 58% | 57% | 33% | 32% |
Breast, Her-2 positive | 73% | 72% | 53% | 52% |
Breast, Her-2 negative | 67% | 66% | 43% | 42% |